Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey
SEROTYPE DISTRIBUTION AND ANTIBIOTIC SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE CAUSING INVASIVE DISEASES IN CHILDREN AND ADULTS: A LABORATORY- BASED MULTICENTER RETROSPECTIVE STUDY
1 other identifier
observational
922
1 country
32
Brief Summary
The aim of this study is to specify the serotype distribution of Streptococcus pneumoniae that causes invasive diseases at children and adults in Turkey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
32 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2013
CompletedFirst Submitted
Initial submission to the registry
March 12, 2013
CompletedFirst Posted
Study publicly available on registry
March 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedApril 6, 2023
December 1, 2020
6.6 years
March 12, 2013
April 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification of S. pneumoniae serotype distribution
4 years
Secondary Outcomes (1)
Identification of antibiotic susceptibility of the isolates
4 years
Study Arms (1)
Serotype distribution (this is a non-interventional study)
Serotype distribution both in pediatrics and adults (this is a non interventional study)
Interventions
This is a non-interventional study.
Eligibility Criteria
Pneumococcal isolates that are obtained from the blood, CSF and/or other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) with the aim of routine laboratory diagnosis from the pediatric patients that are younger than 18 years old (≤18), who are accepted to the pediatric clinic with the diagnosis of meningitides, bacteremia - sepsis or pneumonia, will be included in the trial. S.pneumoniae isolates that meet the inclusion criteria and that are obtained from the invasive clinical samples of the adult patients that are over 18 years old (\>18) and applied to the hospital are included in the trial.
You may qualify if:
- Serotype distribution and antibiotic sensitivity of pneumococcal isolates that causes invasive pneumococcal diseases which are obtained from the blood, CSF, and/or all other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) of the adults of 18 years of age or older with children that are younger than 18 years old at these centers and laboratories will be defined.
You may not qualify if:
- Isolation of any other microorganism than pneumococcus at the same sample.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pfizerlead
Study Sites (32)
Dokuz Eylul University Medical Faculty, Department of Chest Diseases
Balçova, İzmir, 35340, Turkey (Türkiye)
Ankara Yüksek İhtisas Eğitim ve Araştırma Hastanesi Kardiyoloji Kliniği
Ankara / Altındağ, Turkey, 06230, Turkey (Türkiye)
Gaziantep Universitesi Tip Fakultesi Mikrobiyoloji
Gaziantep, Turkiye, Turkey (Türkiye)
Istanbul Universitesi Istanbul Tip Fakultesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali
Istanbul, Turkiye, Turkey (Türkiye)
Cukurova Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
Adana, 01330, Turkey (Türkiye)
Hacettepe Universitesi Tip Fakultesi Cocuk Enfeksiyon Hastaliklari Bilim Dali
Ankara, 06100, Turkey (Türkiye)
Ankara Meslek Hastalıkları Hastanesi
Ankara, Turkey (Türkiye)
Sami Ulus Kadin Dogum Cocuk Sagligi ve Hastaliklari Egitim Arastirma Hastanesi
Ankara, Turkey (Türkiye)
Antalya Egitim ve Arastirma Hastanesi Tibbi Mikrobiyoloji
Antalya, 07100, Turkey (Türkiye)
Akdeniz University Medical Faculty Microbiology Department
Antalya, Turkey (Türkiye)
Akdeniz University Medical Faculty, Microbiology
Antalya, Turkey (Türkiye)
Samsun Ondokuz Mayis Universitesi Tibbi Mikrobiyoloji ABD
Atakum Samsun, 55139, Turkey (Türkiye)
Uludag Universitesi Tip Fakultesi Mikrobiyoloji ve Enfeksiyon Hastaliklari Anabilim Dali
Bursa, Turkey (Türkiye)
Diyarbakir Dicle Universitesi Tibbi Mikrobiyoloji ABD
Diyarbakır, 21280, Turkey (Türkiye)
Dicle Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
Diyarbakır, Turkey (Türkiye)
Firat Universitesi Tip Fakultesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali
Elâzığ, Turkey (Türkiye)
Osmangazi University Medical Faculty, Microbiology
Eskişehir, Turkey (Türkiye)
Marmara Universitesi Tip Fakultesi
Istanbul, 34662, Turkey (Türkiye)
Istanbul Universitesi Cerrahpasa Tip Fakultesi Cocuk Sagligi ve Hastaliklari Ana Bilim Dali
Istanbul, Turkey (Türkiye)
Ege University Medical Faculty, Microbiology
Izmir, Turkey (Türkiye)
İzmir Tepecik Rearch and Training Hospital
Izmir, Turkey (Türkiye)
Istanbul Okmeydani Egitim ve Arastirma Hastanesi Kagithane Semt Poliklinii
Kagithane Istanbul, 34000, Turkey (Türkiye)
Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
Kahramanmaraş, Turkey (Türkiye)
Erciyes University Medical Faculty
Kayseri, Turkey (Türkiye)
Kayseri Training and Research Hospital
Kayseri, Turkey (Türkiye)
Izmir Dr. Behcet Uz Cocuk Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi
Konak Izmir, 35210, Turkey (Türkiye)
Necmettin Erbakan University Meram Faculty of Medicine Deparment of Pediatrics
Konya, Turkey (Türkiye)
Mersin University Medical Faculty, Microbiology
Mersin, Turkey (Türkiye)
Hacettepe University Medical Faculty Hospital
Samanpazari, Ankara, 06100, Turkey (Türkiye)
Selcuk Universitesi Tip Fakultesi Dahili Tip Bilimleri Bolumu Cocuk Sagligi ve Hastaliklari A.B.D
Selcuklu /konya, 42075, Turkey (Türkiye)
Karadeniz Teknik Universitesi Tip Fakultesi Tibbi Mikrobiyoloji Anabilim Dali
Trabzon, Turkey (Türkiye)
Van 100.Yl University Medical Faculty
Van, Turkey (Türkiye)
Related Links
Biospecimen
Blood, CSF and/or other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2013
First Posted
March 14, 2013
Study Start
January 4, 2013
Primary Completion
July 31, 2019
Study Completion
July 31, 2019
Last Updated
April 6, 2023
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\_trials/trial\_data\_and\_results/data\_requests.